|
|
| | MRS 2279 Basic information |
| Product Name: | MRS 2279 | | Synonyms: | MRS 2279;[(1S,2R,4R)-4-[(2-chloro-6-methylaminopurin-9-yl)methyl]-2-(phosphonooxymethyl)cyclopentyl] dihydrogen phosphate;MRS 2279, CID: 5311301;(1R*,2S*)-4-[2-Chloro-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)bicyclo[3.1.0]hexane-1-methanoldihydrogenphosphateesterdiammoniumsalt;Bicyclo[3.1.0]hexane-1-methanol, 4-[2-chloro-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)-, 1-(dihydrogen phosphate), (1R,2S,4S,5S)-;MRS2279,MRS-2279 | | CAS: | 367909-40-8 | | MF: | C13H18ClN5O8P2 | | MW: | 469.71 | | EINECS: | | | Product Categories: | | | Mol File: | 367909-40-8.mol |  |
| | MRS 2279 Chemical Properties |
| Boiling point | 737.021±70.00 °C(Press: 760.00 Torr)(predicted) | | density | 2.251±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | storage temp. | Desiccate at -20°C | | form | Powder | | pka | 1.894±0.10(predicted) | | Water Solubility | Soluble to 100 mM in water |
| | MRS 2279 Usage And Synthesis |
| Uses | MRS 2279 is a selective P2Y1 antagonist with high affinity and results in modulation of aggregation of blood platelets induced by ADP. | | Biological Activity | Selective, high affinity competitive antagonist of the P2Y 1 receptor (K i = 2.5 nM; IC 50 = 51.6 nM). Fails to block nucleotide signaling at most other P2Y receptors (P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 and P2Y 12 ) and potently inhibits ADP-induced aggregation of human blood platelets in vitro (pK B = 8.05). | | in vivo | MRS2279 (2 μL, 1 nM; intracerebroventricular injection; 30 min prior to mechanical ventilation) reduces mouse brain injury induced by mechanical ventilation in high-pressure ventilation mice[3]. | | IC 50 | P2Y1 Receptor: 51.6 nM (IC50) |
| | MRS 2279 Preparation Products And Raw materials |
|